New asthma clinical trial: Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma

Published on: August 06, 2019 at 07:00PM
Conditions:   Eosinophilic Asthma;   Asthma
Interventions:   Drug: low-dose dexpramipexole;   Drug: mid-dose dexpramipexole;   Drug: high-dose dexpramipexole;   Drug: placebo oral tablet
Sponsor:   Knopp Biosciences
Not yet recruiting